Filter by
Date
Cancer type
Cancer stage
Biomarker
Method of analysis
Selected categories
June, 2024
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
March, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
January 2024
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation
Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
January 2024
Molecular Profiling of Circulating Tumour Cells and Circulating Tumour DNA: Complementary Insights from a Single Blood Sample Utilising the Parsortix System
ANGLE Europe Limited, Guildford, UK published by journal of Current Issues in Molecular Biology
December 2023
Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy
Trinity College Dublin, Ireland published by the journal Frontiers in Cell and Developmental Biology
November, 2023
Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis
Department of Internal Medicine, University of New Mexico Health Sciences Center, United States
1
23 ...
16